Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of the National Cancer Institute

• Publication date

  1998-05-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/90.9.697PMID 9586667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular genetic studies of early breast cancer evolution

  2004cited by this paper
• Chromosome 11q13 markers and D-type cyclins in breast cancer

  2004cited by this paper
• Loss of heterozygosity on chromosome 11 q 13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction

  1997cited by this paper
• Analysis of loss of heterozygosity on chromosome 11q13 in atypical ductal hyperplasia and in situ carcinoma of the breast.

  1997cited by this paper
• Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction.

  1997cited by this paper
• Loss of heterozygosity and microsatellite instability in breast hyperplasia. No obligate correlation of these genetic alterations with subsequent malignancy.

  1997cited by this paper
• Loss of heterozygosity at chromosome 6q in preinvasive and early invasive breast carcinomas.

  1997cited by this paper
• High levels of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers.

  1996cited by this paper
• Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas

  1996cited by this paper
• Genetic divergence in the clonal evolution of breast cancer.

  1996cited by this paper
• Detection of monoclonal microsatellite alterations in atypical breast hyperplasia.

  1996cited by this paper
• Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast.

  1996cited by this paper
• Detection of allelic imbalance indicates that a proportion of mammary hyperplasia of usual type are clonal, neoplastic proliferations.

  1996cited by this paper
• Loss of heterozygosity in lobular carcinoma in situ of the breast

  1995cited by this paper
• Identical allelic loss on chromosome 11q13 in microdissected in situ and invasive human breast cancer.

  1995cited by this paper
• E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.

  1995cited by this paper
• Loss of heterozygosity in ductal carcinoma in situ of the breast

  1995cited by this paper
• Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q.

  1995cited by this paper
• Loss of heterozygosity of the oestrogen receptor gene in breast cancer.

  1995cited by this paper
• Allelic loss and the progression of breast cancer.

  1995cited by this paper
• Clonal analysis of benign and malignant human breast tumors by means of polymerase chain reaction.

  1995cited by this paper
• Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p.

  1995cited by this paper
• Comparative allelotype of in situ and invasive human breast cancer: high frequency of microsatellite instability in lobular breast carcinomas.

  1995cited by this paper
• Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast.

  1995cited by this paper
• Clonal analysis of predominantly intraductal carcinoma and precancerous lesions of the breast by means of polymerase chain reaction.

  1994cited by this paper
• The search for BRCA1.

  1994cited by this paper
• Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

  1994cited by this paper
• Clonal chromosome-aberrations in fibrocystic breast disease-associated with increased risk of cancer.

  1994cited by this paper
• Allelic loss on a chromosome 17 in ductal carcinoma in situ of the breast.

  1993cited by this paper
• Prognostic significance of benign proliferative breast disease

  1993cited by this paper
• Breast cancer risk associated with proliferative breast disease and atypical hyperplasia

  1993cited by this paper
• Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome

  1992cited by this paper
• Histologic types of benign breast disease and the risk for breast cancer

  1992cited by this paper
• Risk of breast cancer after benign breast diseases. Variation by histologic type, degree of atypia, age at biopsy, and length of follow-up.

  1992cited by this paper
• A prospective study of benign breast disease and the risk of breast cancer

  1992cited by this paper
• Genetic basis for p53 overexpression in human breast cancer.

  1991cited by this paper
• Benign breast disease and breast cancer: A case‐control study in a cohort in italy

  1991cited by this paper
• Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas.

  1991cited by this paper
• p53 mutations in human cancers.

  1991cited by this paper
• Identification of the neurofibromatosis type 1 gene product.

  1991cited by this paper
• Premalignant conditions and markers of elevated risk in the breast and their management.

  1990cited by this paper
• 19 – SAMPLE PREPARATION FROM PARAFFIN-EMBEDDED TISSUES

  1990cited by this paper
• Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.

  1990cited by this paper
• Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

  1990cited by this paper
• A Follow-up Study

  1990cited by this paper
• A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations.

  1990cited by this paper
• Mutations in the p53 gene occur in diverse human tumour types

  1989cited by this paper
• Importance of cellular DNA content in pre‐malignant breast disease and pre‐invasive carcinoma of the female breast

  1987cited by this paper
• Human retinoblastoma susceptibility gene: cloning, identification, and sequence

  1987cited by this paper
• Breast cancer risk of lobular-based hyperplasia after biopsy: "ductal" pattern lesions.

  1986cited by this paper
• Cancer risk assessment in benign breast biopsies.

  1986cited by this paper
• Atypical hyperplastic lesions of the female breast. A long‐term follow‐up study

  1985cited by this paper
• Risk factors for breast cancer in women with proliferative breast disease.

  1985cited by this paper
• Expression of recessive alleles by chromosomal mechanisms in retinoblastoma

  1983cited by this paper
• :A long term follow-up study

  1982cited by this paper
• Intraductal carcinoma of the breast: Follow‐up after biopsy only

  1982cited by this paper
• Risk of breast cancer in women with benign breast disease.

  1980cited by this paper
• Relation between component parts of fibrocystic disease complex and breast cancer.

  1978cited by this paper
• Chronic mastopathy and breast cancer: A Follow‐Up Study

  1977cited by this paper
• An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.

  1975cited by this paper
• On the origin and progression of ductal carcinoma in the human breast.

  1973cited by this paper
• Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer

  1972cited by this paper
• Cystic disease of the breast: Relationship to carcinoma

  1964cited by this paper
• Comparative Studies of Cancerous Versus Noncancerous Breasts.

  1945cited by this paper
• COMPARATIVE STUDIES OF CANCEROUS VERSUS NONCANCEROUS BREASTS

  1945cited by this paper
• On the changes in the mammary gland preceding carcinoma

  year unknowncited by this paper

• Atypical Ductal Hyperplasia of the Breast: A Narrative Review

  2024cites this paper
• Ductal Carcinoma in Situ: A Detailed Review of Current Practices

  2023cites this paper
• Changes in mRNA expression of oncogenesis driver genes in atypical ductal breast hyperplasia

  2023cites this paper
• Establishment of a 3D co‐culture model to investigate the role of primary fibroblasts in ductal carcinoma in situ of the breast

  2022cites this paper
• Field cancerization in breast cancer

  2022cites this paper
• Establishment of a 3D co–Culture Model to Investigate the Role of Primary Fibroblasts in DCIS of the Breast.

  2021cites this paper
• The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer

  2021cites this paper
• Heterogeneity of circulating tumour cell-associated genomic gains in breast cancer and its association with the host immune response

  2021cites this paper
• Heterogeneity of Circulating Tumor Cell–Associated Genomic Gains in Breast Cancer and Its Association with the Host Immune Response

  2021cites this paper
• The Natural History of Ductal Carcinoma In Situ of the Breast - An Overview.

  2021cites this paper
• The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer

  2021cites this paper
• Management of high-risk breast lesions diagnosed on core biopsies and experiences from prospective high-risk breast lesion conferences at an academic institution

  2020cites this paper
• Atypical ductal hyperplasia is a multipotent precursor of breast carcinoma

  2019cites this paper
• Genetic Alterations in Benign Breast Biopsies of Subsequent Breast Cancer Patients

  2019cites this paper
• Whole transcriptome analysis identifies upregulated genes and pathways in ductal carcinoma in situ mimicking usual ductal hyperplasia

  2019cites this paper
• Intraductal Proliferative Disease of the Breast

  2019cites this paper
• BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ

  2019cites this paper
• Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS

  2019cites this paper
• Hormone-Responsive Cancers

  2019cites this paper
• Preinvasive Breast Lesions: Detection and Management

  2019cites this paper
• Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers

  2018cites this paper
• Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape

  2018cites this paper
• Molecular genetics of lobular breast cancer ductal carcinoma in situ

  2018cites this paper
• Breast and Axilla Treatment in Ductal Carcinoma In Situ

  2018cites this paper
• The PPARγ agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ

  2018cites this paper
• Chapter 8 Breast and Axilla Treatment in Ductal Carcinoma In Situ

  2018cites this paper
• Beyond DNA: the Role of Epigenetics in the Premalignant Progression of Breast Cancer

  2018cites this paper
• Chapter 4 Early-Stage Progression of Breast Cancer

  2018cites this paper
• Non-classic LCIS Versus Classic LCIS Versus Atypical Hyperplasia: Should Management be the Same?

  2018cites this paper
• Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB2 Status.

  2017cites this paper
• Molecular profile of atypical hyperplasia of the breast

  2017cites this paper
• Premalignant and pre-invasive lesions of the breast

  2017cites this paper
• A NOVEL APPROACH FOR THE IDENTIFICATION OF CANDIDATE DRIVER LESIONS IN BREAST CANCER BASED ON THE COMPARISON OF THE MUTATIONAL PROFILES OF A PRIMARY TUMOUR AND ITS MATCHED MAMMOSPHERES AND XENOGRAFT.

  2017cites this paper
• Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast

  2017cites this paper
• Contemporary challenges in molecular oncology and pathology of the breast

  2017cites this paper
• Towards a personalized surgical margin for breast conserving surgery—Implications of field cancerization in local recurrence

  2017cites this paper
• Prise en charge des hyperplasies canalaires atypiques : pertinence du schéma décisionnel du CLCC de Lyon, analyse rétrospective sur une série de patientes de l’Institut Curie

  2017cites this paper
• Aromatase expression in atypical ductal hyperplasia in women

  2017cites this paper
• Differential Gene Expression in Ductal Carcinoma In Situ of the Breast Based on ERBB 2 Status

  2017cites this paper
• Pathology and Molecular Pathology of Breast Cancer

  2017cites this paper
• Deciphering the molecular signaling pathways in breast cancer pathogenesis and their role in diagnostic and treatment modalities

  2017cites this paper
• Intraductal Proliferative Lesions

  2017cites this paper
• Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis

  2017cites this paper
• Finding the balance between overtreatment and undertreatment of ductal carcinoma in situ

  2017cites this paper
• Telomeres in cancer: tumour suppression and genome instability

  2017cites this paper
• Early-Stage Progression of Breast Cancer

  2017cites this paper
• Clinical and pathological assessment of high-risk ductal and lobular breast lesions: What surgeons must know.

  2017cites this paper
• Invasive Ductal Carcinoma Including Microinvasive Carcinoma, Tubular Carcinoma, and Cribriform Carcinoma

  2016cites this paper
• Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer.

  2016cites this paper
• Ductal Carcinoma In Situ

  2016cites this paper
• Cancer stem cells and early stage basal-like breast cancer

  2016cites this paper
• Mutation Profiling of Usual Ductal Hyperplasia of the Breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR Pathway.

  2016cites this paper
• Clinical characteristics and management of a Greek female patient cohort with breast ductal carcinoma in situ.

  2016influential citation
• Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model

  2016cites this paper
• Molecular Features of Sub type-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer Graphical

  2016cites this paper
• miRNAs as potential biomarkers in early breast cancer detection following mammography

  2016cites this paper
• Chapter 62 – Noninvasive Breast Cancer

  2016cites this paper
• Investigating telomerase regulation in human breast cancer cells: a search for telomerase repressor sequences localised to chromosome 3P

  2015cites this paper
• Ductal Carcinoma In Situ of the Breast

  2015cites this paper
• Selection and evolution in the genomic landscape of copy number alterations in ductal carcinoma in situ (DCIS) and its progression to invasive carcinoma of ductal/no special type: a meta-analysis

  2015cites this paper
• Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer

  2015cites this paper
• Reduced MUC4 Expression is a Late Event in Breast Carcinogenesis and is Correlated With Increased Infiltration of Immune Cells as Well as Promoter Hypermethylation in Invasive Breast Carcinoma

  2015cites this paper
• Loss of heterozygosity in tumor tissue in hormonal receptor genes is associated with poor prognostic criteria in breast cancer.

  2015cites this paper
• Molecular Pathology of Precancerous Lesions of the Breast

  2015cites this paper
• Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

  2015cites this paper
• Histopathological Features of Non-Neoplastic Breast Parenchyma Do Not Predict BRCA Mutation Status of Patients with Invasive Breast Cancer

  2015cites this paper
• Molecular Pathology of Pre-Invasive Ductal Carcinoma

  2015cites this paper
• Human Cancer Biology PI 3 K Pathway Activation in High-Grade Ductal Carcinoma In Situ — Implications for Progression to Invasive Breast Carcinoma

  2014influential citation
• Molecular classification of breast cancer

  2014cites this paper
• Randomized controlled trial of

  2014cites this paper
• Estrogen Signaling and the DNA Damage Response in Hormone Dependent Breast Cancers

  2014cites this paper
• Epithelial Proliferative Lesions

  2014cites this paper
• Chapter 29 – Hormone Responsive Cancers

  2014cites this paper
• Pathology and Biological Markers of Invasive Breast Cancer

  2014cites this paper
• PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma

  2014cites this paper
• PI 3 K pathway activation in high-grade ductal carcinoma in situ — implications for progression to invasive breast carcinoma

  2014cites this paper
• Development of an organotypic 3D in vitro model of normal human breast tissue : a tool for cancer initiation studies

  2014influential citation
• Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions

  2014cites this paper
• Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study

  2014cites this paper
• This Provisional PDF corresponds to the article as it appeared upon acceptance. Copyedited and fully formatted PDF and full text (HTML) versions will be made available soon. A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions

  2014cites this paper
• Current role of immunotherapy for the treatment of prostate cancer.

  2013cites this paper
• Ductal carcinoma in situ associated with triple negative invasive breast cancer: evidence for a precursor–product relationship

  2013cites this paper
• Progression from ductal carcinoma in situ to invasive breast cancer: Revisited

  2013cites this paper
• Chromosome 16q loss--a genetic key to the understanding of breast carcinogenesis.

  2013cites this paper
• Progression of Early Breast Cancer to an Invasive Phenotype

  2013cites this paper
• Assessment of DNA methylation status in early stages of breast cancer development

  2013cites this paper
• Ductal carcinoma in situ: a rose by any other name.

  2013cites this paper
• Treatment of ductal carcinoma in situ after excision: would a prophylactic paradigm be more appropriate?

  2013cites this paper
• Influence of the in situ component in 389 infiltrating ductal breast carcinomas

  2013cites this paper
• Does digital mammography increase detection of high-risk breast lesions presenting as calcifications?

  2013cites this paper
• Breast cancer precursors: diagnostic issues and current understanding on their pathogenesis

  2013cites this paper
• Prostate cancer screening: biases and the need for consensus.

  2013cites this paper
• Suppression of Mammary Tumorigenesis by a Gemini Vitamin D Analog and a Synthetic Triterpenoid

  2013cites this paper
• Tumorigenesis and Neoplastic Progression Single-Cell Genetic Analysis of Ductal Carcinoma in Situ and Invasive Breast Cancer Reveals Enormous Tumor Heterogeneity yet Conserved Genomic Imbalances and Gain of MYC during Progression

  2012cites this paper
• Epigenetic progression of columnar cell lesions of the breast to invasive breast cancer

  2012cites this paper
• Differential copy number aberrations in novel candidate genes associated with progression from in situ to invasive ductal carcinoma of the breast

  2012cites this paper
• Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study

  2012cites this paper
• The r ole of non-canonical Wnt/planar cell polarity signalling in breast cancer progression

  2012cites this paper
• Intraductal Proliferative Lesions of the Breast—Terminology and Biology Matter: Premalignant Lesions or Preinvasive Cancer?

  2012cites this paper
• Investigational Paradigms in Downscoring and Upscoring DCIS: Surgical Management Review

  2012cites this paper